Stock comparison
LivaNova
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LIVN
LivaNova
Market cap
$4.06B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LIVN | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 35D | 69B | MTD |
| Benjamin Graham | 61D | 65B | MTD |
| Philip Fisher | 43D | 63C | MTD |
| Peter Lynch | 36D | 66B | MTD |
| Joel Greenblatt | 36D | 68B | MTD |
| Charlie Munger | 36D | 74B | MTD |
| Terry Smith | 29F | 70B | MTD |
Side-by-side metrics
| Metric | LIVN | MTD |
|---|---|---|
| Market cap | $4.06B | $22.29B |
| P/E (TTM) | 36.9x | 25.3x |
| EV/EBIT | 18.9x | 21.6x |
| ROIC (TTM) | 10.19% | 36.09% |
| Gross margin | 67.57% | 57.79% |
| Net margin | 7.47% | 21.4% |
| Revenue CAGR 5y | 7.6% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 0.3x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LIVN leads on
- Revenue CAGR 5y7.6%vs 2.01%+74%
- Gross margin67.57%vs 57.79%+14%
- EV/EBIT18.9xvs 21.6x+13%
MTD leads on
- Debt / Equity-vs 0.3x+101%
- Market cap$22.29Bvs $4.06B+82%
- ROIC (TTM)36.09%vs 10.19%+72%
- Net margin21.4%vs 7.47%+65%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.